Induction of a Selective and Persistent Extravasation of Neutrophils into the Peritoneal Cavity by Tryptase Mouse Mast Cell Protease 6
Open Access
- 15 February 1998
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 160 (4) , 1910-1919
Abstract
Recombinant mouse mast cell protease 6 (mMCP-6) was generated to study the role of this tryptase in inflammatory reactions. Seven to forty-eight hours after the i.p. injection of recombinant mMCP-6 into BALB/c, mast cell-deficient WCB6F1-Sl/Sld, C5-deficient, or mMCP-5-null mice, the number of neutrophils in the peritoneal cavity of each animal increased significantly by >50-fold. The failure of the closely related recombinant tryptase mMCP-7 to induce a comparable peritonitis indicates that the substrate specificities of the two tryptases are very different. Unlike most forms of acute inflammation, the mMCP-6-mediated peritonitis was relatively long lasting and neutrophil specific. Mouse MCP-6 did not induce neutrophil chemotaxis directly in an in vitro assay, but did promote chemotaxis of the leukocyte in the presence of endothelial cells. Mouse MCP-6 did not induce cultured human endothelial cells to express TNF-α, RANTES, IL-1α, or IL-6. However, the tryptase induced endothelial cells to express large amounts of IL-8 continually over a 40-h period. Neither enzymatically active mMCP-7 nor enzymatically inactive pro-mMCP-6 was able to induce endothelial cells to increase their expression of IL-8. Although the mechanism by which mMCP-6 induces neutrophil accumulation in tissues remains to be determined, the finding that mMCP-6 induces cultured human endothelial cells to selectively release large amounts of IL-8 raises the possibility that this tryptase regulates the steady state levels of neutrophil-specific chemokines in vivo during mast cell-mediated inflammatory events.Keywords
This publication has 57 references indexed in Scilit:
- The Tryptase, Mouse Mast Cell Protease 7, Exhibits Anticoagulant Activity in Vivo and in Vitro Due to Its Ability to Degrade Fibrinogen in the Presence of the Diverse Array of Protease Inhibitors in PlasmaJournal of Biological Chemistry, 1997
- In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptorsJournal of Laboratory and Clinical Medicine, 1996
- Packaging of Proteases and Proteoglycans in the Granules of Mast Cells and Other Hematopoietic CellsJournal of Biological Chemistry, 1995
- Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitorImmunity, 1995
- Mast cell tryptases: Examination of unusual characteristics by multiple sequence alignment and molecular modelingProtein Science, 1992
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Cloning and characterization of a second complementary DNA for human tryptase.Journal of Clinical Investigation, 1990
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989
- B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cellsCell, 1987
- Comparison of three actin-coding sequences in the mouse; Evolutionary relationships between the actin genes of warm-blooded vertebratesJournal of Molecular Evolution, 1986